[HTML][HTML] Type II diabetes mellitus: a review on recent drug based therapeutics
S Padhi, AK Nayak, A Behera - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Diabetes mellitus (DM) is a metabolic disorder that occurs in the body because of decreased
insulin activity and/or insulin secretion. Pathological changes such as nephropathy …
insulin activity and/or insulin secretion. Pathological changes such as nephropathy …
[HTML][HTML] Management of type 2 diabetes: current strategies, unfocussed aspects, challenges, and alternatives
Type 2 diabetes mellitus (T2DM) accounts for> 90% of the cases of diabetes in adults.
Resistance to insulin action is the major cause that leads to chronic hyperglycemia in …
Resistance to insulin action is the major cause that leads to chronic hyperglycemia in …
From diabetes to atherosclerosis: potential of metformin for management of cardiovascular disease
AV Poznyak, L Litvinova, P Poggio… - International journal of …, 2022 - mdpi.com
Atherosclerosis is a common cause of cardiovascular disease, which, in turn, is often fatal.
Today, we know a lot about the pathogenesis of atherosclerosis. However, the main …
Today, we know a lot about the pathogenesis of atherosclerosis. However, the main …
[HTML][HTML] DAPAGLIFLOZIN: A NEW HOPE FOR THE THERAPEUTIC TREATMENT OF TYPE 2 DIABETES MELLITUS
Diabetes mellitus (Type 2) is a major world health problem spreading speedily throughout
the world. It is a chronic illness that necessitates long-term therapy and care. Therefore, the …
the world. It is a chronic illness that necessitates long-term therapy and care. Therefore, the …
Nanotechnology in diabetes Management: Revolutionizing treatment and diagnostics
K Yadav - Journal of Molecular Liquids, 2024 - Elsevier
The global health landscape is witnessing a paradigm shift as diabetes emerges as a
formidable challenge to conventional medical interventions. This metabolic disorder …
formidable challenge to conventional medical interventions. This metabolic disorder …
RSSDI consensus recommendations on insulin therapy in the management of diabetes
R Chawla, BM Makkar, S Aggarwal, S Bajaj… - International Journal of …, 2019 - Springer
Abstract The Research Society for the Study of Diabetes in India (RSSDI) has regularly
updated its Clinical Practice Guidelines on various aspects of diabetes. The …
updated its Clinical Practice Guidelines on various aspects of diabetes. The …
Acute Kidney Injury and Electrolyte Imbalances Caused by Dapagliflozin Short-Term Use
AC Lopes, O Lourenço, S Morgado, A Gaspar, I Freire… - Pharmaceuticals, 2024 - mdpi.com
Dapagliflozin, a sodium–glucose cotransporter 2 inhibitor (SGLT2i), has shown
demonstrated benefits for renal and cardiovascular outcomes in large clinical trials …
demonstrated benefits for renal and cardiovascular outcomes in large clinical trials …
Microalgae as a potential sustainable solution to environment health
HSH Munawaroh, F Hazmatulhaq, GG Gumilar… - Chemosphere, 2022 - Elsevier
Cyanobacteria such as Spirulina platensis secretes numerous biomolecules while
consuming CO 2 for photosynthesis which can reduce the environmental pollution as it can …
consuming CO 2 for photosynthesis which can reduce the environmental pollution as it can …
Dapagliflozin, a sodium glucose cotransporter 2 inhibitors, protects cardiovascular function in type-2 diabetic murine model
S Saleh, G Hanna, SH El-Nabi, H El-Domiaty… - Journal of Genetics, 2020 - Springer
Diabetes mellitus and its complications are major international health problems in which
there are many limitations to the orthodox approaches in the treatment. Sodium glucose …
there are many limitations to the orthodox approaches in the treatment. Sodium glucose …
Novel Approaches for the Management of Type 2 Diabetes Mellitus: An Update
Diabetes mellitus is an irreversible, chronic metabolic disorder indicated by hyperglycemia.
It is now considered a worldwide pandemic. T2DM, a spectrum of diseases initially caused …
It is now considered a worldwide pandemic. T2DM, a spectrum of diseases initially caused …